Labcorp has signed a definitive agreement for the acquisition of select ambulatory outreach laboratory assets from Community Health Systems (CHS) for $195m in cash. This strategic move will expand ...

After hanging out the for sale sign and filing for bankruptcy earlier this year, the genetic testing provider Invitae has found a new home for its portfolio at Labcorp. The two companies announced ...

The deal includes outreach laboratory services in 13 states. CHS will continue to operate its inpatient and emergency department labs along with other hospital-based testing services. Like its chief ...

Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...

Invitae’s business operations are heading to a new home. Under a bankruptcy auction, Labcorp was selected as the winning bidder for the firm’s genetic testing services, digital health solutions, and ...

LabCorp has now become the first company to receive approval to sell its COVID-19 test kit over-the-counter without a prescription, according to a statement from the company. One of the largest ...

Medical testing giant LabCorp is still recovering from a ransomware attack nearly a week later, but won’t say just how the hackers got in nor how many servers were impacted. LabCorp was forced to shut ...

Labcorp delivered mixed third-quarter results, with higher sales and raised profit guidance but a lower full-year revenue forecast as it “takes action” on an underperforming unit. First, overall sales ...

LabCorp, one of the largest clinical laboratory companies in the world, is now giving consumers the option to order their own blood tests online as it positions itself for a major expansion of ...

Labcorp is updating 2025 full year guidance to reflect its third quarter performance and full year outlook. The following guidance assumes foreign exchange rates effective as of September 30, 2025, ...

Labcorp’s testing capabilities are getting a little broader with the $237.5 million acquisition of certain laboratory assets from BioReference Health, a subsidiary of Opko Health. The BioReference ...